Arul Nancy - Concepedia

Author

Arul Nancy

National Institute of Research in Tuberculosis ORCID

Also Known As

A. Nancy, Arul Nancy, Arul P. Nancy

Publications

567

Citations

H-Index

Concepts

All Affiliations

National Institute of Research in Tuberculosis India Diabetes Research Foundation International Centers for Excellence in Research University of Massachusetts Chan Medical School National Institute of Allergy and Infectious Diseases

About

Arul Nancy is an author at National Institute of Research in Tuberculosis specializing in immunology, medicine, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	189
2	Immunology	6	6	189
3	Diabetes	1	1	10
4	Epidemiology	1	1	10
5	Pathology	1	1	77

Arul Nancy

Publications

519

Citations

H-Index

Page 1

	Year	Citations
Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma R. P. Baum, A. Niesen, A. Hertel, Cancer Immunocytochemical TechniqueImmunologyPathologyImmunophenotypingImmunotherapy	1994	77
Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Scientific Reports	2019	59
Effect of BCG vaccination on proinflammatory responses in elderly individuals Nathella Pavan Kumar, Chandrasekaran Padmapriyadarsini, Anuradha Rajamanickam, Science Advances VaccinationVaccinologyVaccine SafetyInflammationBcg Vaccination	2021	44
Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Clinical Infectious Diseases	2020	38
Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Frontiers in Cellular and Infection Microbiology	2019	32
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, JAMA Network Open	2020	32
Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection Anuradha Rajamanickam, Nathella Pavan Kumar, Chandrasekaran Padmapriyadarsini, Journal of Infection	2021	32
Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co‐morbidity Nathella Pavan Kumar, Kadar Moideen, Yukthi Bhootra, Immunology	2018	28
Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine Responses Nathella Pavan Kumar, V.V. Banurekha, Girish Kumar C P, Frontiers in Immunology Prime-boost VaccinationImmunologyImmune RegulationImmunologic MechanismInnate Immunity	2021	21
Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure Nathella Pavan Kumar, Kadar Moideen, Arul Nancy, Frontiers in Immunology InflammationPrognostic EvaluationPrognostic BiomarkersPulmonary TuberculosisDisease Progression	2021	19

Page 1